Why Tasmania?

International Therapeutic Proteins Ltd

Manufacturing operations are based just outside Launceston, the second largest city in Tasmania. Launceston is Australia's third oldest city and is part of the Tamar Valley, a region of stunning scenery dotted with quaint villages and wineries.

Tasmania is an ideal source for the production of biological therapeutics for the following reasons:

•  It has exceptionally high animal health status, with enforcement at all ports of entry. The island is free from cattle and sheep diseases of concern, including BSE, scrapie, FMD, rabies, rinderpest and brucellosis. Australia has Level 1 status in the EU for freedom from BSE. This provides a starting material (Active Pharmaceutical Ingredient) of the highest safety and quality that is BSE-free;
  
  
•  Australia is a global leader in technology driven, nationalized livestock traceability (NLIS). For more information please refer to www.animalhealthaustralia.com.au ;
  
  
•  The island is recognised for its discreet manufacturing capabilities: it is the world’s largest producer of medicinal opiates.